Eton’s Rezipres (ephedrine hydrochloride injection) Receives the US FDA’s Approval for the Treatment of Hypotension

Shots:

• The US FDA has approved Rezipres for the treatment of hypotension that occurs in the setting of anesthesia
• Rezipres is a sulfite-free formulation that has been sold successfully in the EU for years. Additionally, the company is expected to make it available for US patients shortly
• Currently, the company receives royalties from four FDA-approved products, including Alkindi Sprinkle, Biorphen, Rezipres, and Alaway Preservative Free, and has five additional products that have been submitted to the FDA

Click here to­ read full press release/ article | Ref: Globe Newswire | Image: Linkedin